Otonomy (OTIC) Commences Phase 3 Clinical Trial of OTIVIDEX in Meniere's Disease

July 26, 2018 8:18 AM

Otonomy, Inc. (NASDAQ: OTIC) today announced initiation of the additional Phase 3 trial required to support a submission for U.S ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found